Diabetes Care, Vol 23, Issue 4 539-543, Copyright © 2000 by American Diabetes Association

ARTICLES

Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension

J Valabhji, S Robinson, C Poulter, AC Robinson, C Kong, C Henzen, WM Gedroyc, MD Feher and RS Elkeles
Section of Endocrinology and Metabolic Medicine, Imperial College School of Medicine, St. Mary's Hospital, London, U.K. j.valabhji@ic.ac.uk

OBJECTIVE: To assess the prevalence of renal artery stenosis (RAS) in subjects with type 2 diabetes and coexistent hypertension by using magnetic resonance angiography (MRA) of the renal arteries, to assess clinical and biochemical predictors of RAS, and to assess the hemodynamic significance of RAS, by using the captopril test (a measure of the response of plasma renin activity to a single oral dose of captopril). RESEARCH DESIGN AND METHODS: A total of 117 subjects with type 2 diabetes and coexistent hypertension between 40 and 70 years of age and with creatinine concentrations < 150 micromol/l were recruited from two inner-city general diabetes clinics. All subjects underwent MRA of the renal arteries. In a subgroup of 85 subjects, data concerning possible clinical and biochemical predictors of RAS were collected, and the captopril test was performed. For comparison of a continuous variable between subjects with a positive MRA and those with a negative MRA, the Mann-Whitney test was used. For comparison of a discrete variable between subjects with a positive MRA and those with a negative MRA, Fisher's exact test was used. RESULTS: The prevalence of RAS detected by using MRA in 117 hypertensive type 2 diabetic subjects was 17%; 19 subjects had unilateral RAS, and only 1 subject had bilateral RAS. A femoral bruit was significantly more common in subjects with a positive MRA versus subjects with a negative MRA (21 vs. 0%; Fisher's exact test P < 0.005); however, other clinical features of atherosclerotic disease were not statistically associated. Greater duration of hypertension and treatment with statins were features of subjects with RAS (P < 0.05). The captopril test was negative in all subjects, although the antihypertensive response to oral captopril was significantly greater in subjects with RAS detected by MRA. CONCLUSIONS: RAS is common in hypertensive type 2 diabetic subjects. The presence of a femoral bruit is a useful predictive clinical marker. The captopril test is not useful in predicting the hemodynamic significance of RAS in this patient group.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis Hypertension, February 1, 2008; 51(2): 466 - 473. [Abstract] [Full Text] [PDF]

				A. Karagiannis, K. Tziomalos, K. Dona, A. Pyrpasopoulou, N. Kartali, V. Athyros, and C. Zamboulis Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient QJM, December 1, 2005; 98(12): 913 - 915. [Full Text] [PDF]

				N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis Matrix Metalloproteinases and Diabetic Vascular Complications Angiology, March 1, 2005; 56(2): 173 - 189. [Abstract] [PDF]

				J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]

				D. Weber-Mzell, P. Kotanko, M. Schumacher, W. Klein, and F. Skrabal Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease Eur. Heart J., November 1, 2002; 23(21): 1684 - 1691. [Abstract] [Full Text] [PDF]

				J. D Walker Review: Angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in diabetic renal disease The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 81 - 84. [Abstract] [PDF]

				C. J Hay and P. A Kalra Review: Renovascular disease in diabetic patients The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 91 - 95. [Abstract] [PDF]

				M. Page Diabetic renal disease: who to refer, when to refer The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 112 - 114. [PDF]

				M. A J Devonald and F. E Karet Targeting the renin-angiotensin system in patients with renal disease J R Soc Med, January 8, 2002; 95(8): 391 - 397. [Full Text] [PDF]